Competitive
Intelligence
Services
Strengthen your market position through actionable insights and forward-looking strategies tailored to your business goals
Contact UsDeep, Domain
Specific Expertise
Unlock strategic advantage with our Competitive Intelligence services, purpose built to address your most essential challenges and drive new growth for your pharma, biotech, life sciences and healthcare businesses. We deliver impact through:
- A unique blend of deep, domain specific expertise revealing high value opportunities.
- Integrated insights that drive strategic decision and accelerate your competitive advantage.
- Transforming fragmented data into powerful, actionable insights – illuminating opportunities in emerging technologies and therapeutic silos to fuel your growth.
Transform Strategic Decisions with Competitive Intelligence
Gain Insights into
Pharmaceuticals Markets
Explore comprehensive data and trends shaping the global pharmaceutical industry.
Evolving Competitor
Strategies
Track and analyze the dynamic shifts in competitor strategies.
Emerging Opportunities with our
Expert CI Services
Leverage our CI experts to proactively unlock new market opportunities.
Our CI Services
Real-world examples of CI-driven insight, sharper strategy, and
measurable business impact
-
Drug Discovery
-
Research & Development
-
Commercialization
-
Sales & Marketing Intelligence
-
Primary Research
-
Ongoing CI Monitoring
Clinical Trial
Tracking
Tracking
KOL
Assessment
Assessment
Investment
Analysis
Analysis
Technology
Scouting
Scouting
Product
Discontinuation
Discontinuation
Unmet Need
Analysis
Analysis
Why Competitive Intelligence with Roots
Analysis?
We leverage our in-house
expertise to address the entire breadth of business requirements. This passion enables a powerful
commitment: To unlock the true value of
data for your business.
200+
Years of Collective Experience
We bring deep expertise across pharma and biotech, life sciences, medical devices and
diagnostics, offering tailored and actionable insights
70+
Analytical Frameworks
We have designed and developed highly insightful proprietary analytical frameworks that simplify
decision making for our clients.
40%
Clients are Pharma Giants
We work with Fortune 500 companies, start-ups, academia, venture capitalists and strategic
investors
investors
Change We Created
Designing a GTM Model for Rapid Digital Therapeutic Adoption
A digital therapeutics startup used real-time market insights to redesign
its GTM approach and resolve adoption barriers quickly
The Customer Verdict: Evidence-Based Insights for Growth
In a groundbreaking Voice of the Customer (VoC) initiative, a leading
pharma technology provider leveraged key performance metrics to overhaul customer
experiences and improve the product quality
Decoding GLP-1 Complexity for Series B Success
A mid-sized drug developer leveraged our pipeline tracking intelligence to
decode the GLP-1 landscape, forecast growth potential and adopt proven learnings from
industry leaders
Evidence-Based Risk Profiling for Sema3A Pharmacological Inhibition
The UK R&D team of a multinational pharmaceutical company leveraged our
literature analysis to evaluate the safety profile of Sema3A inhibition
Data‑Driven Competitor Profiling for Smarter APAC Peptide Growth
In a focused competitor profiling initiative, a peptide API manufacturer used
deep dives into CMOs based in APAC to optimize supply chain resilience and unlock more
profitable deals
The Influence Blueprint: Evidence‑Led KOL Insights for Smarter Growth
In a strategic KOL Analysis initiative, a leading pharmaceutical manufacturer used evidence‑based influence mapping to sharpen expert engagement, accelerate trial delivery, and strengthen launch outcomes
The Revenue Catalyst: Data‑Driven Market Sizing for Smarter Cannabis Lab Growth
In a focused Market Sizing initiative, a Florida-based cannabis testing laboratory used data‑driven demand modeling to sharpen commercial targeting, optimize capacity investments and unlock more profitable, scalable growth across the state
Provide end to end conference coverage on PD-1 inhibitor antibodies for solid tumors
A PD-1 inhibitor focused mid sized firm used detailed insights shared from the conference coverage to understand
recent developments
Evidence Powers Global Pharma Hematology Strategy
A global pharma leader leveraged our therapeutic area assessment intelligence to refine its commercial strategy and accelerate market positioning across rare hematological indications
Mapping Gene Therapy Demand for Smarter, Low‑Risk Scale‑Up
A large Germany‑based bioprocess company used our demand‑modeling intelligence to build a clear, volume‑based view of gene therapy APIs, enabling stronger capacity planning, lower investment risk and better alignment of technology platforms with high‑growth therapeutic indications
Plant-Based Meat Brand’s Competitive Advertising Intelligence
In the rapidly evolving landscape of vegan meats, a plant-based meat manufacturer leveraged Roots Analysis’ focused advertising & campaign analysis framework to decode competitors’ strategies and build upon the strategic recommendations provided
The Digital Health Blue Ocean: Supporting a Connected Device Developer
A connected drug-delivery device developer leveraged our data‑driven blue ocean strategy to strengthen market positioning and unlock more profitable, scalable growth across the industry
Catheter Manufacturer's Distribution Network Optimization
The client, a mid-sized catheter manufacturer, partnered with Roots Analysis to conduct a thorough channel partner analysis of competitors' distribution strategies and partner ecosystems
The Industry Edge: Competitor Monitoring for Strategic European Fill-Finish Positioning
In a targeted competitor monitoring project, a fill-finish equipment provider leveraged in-depth analyses of rivals' deals and initiatives across Europe, to enhance market foresight and secure stronger partnerships within the region.
Mapping Biologics Contract Manufacturing Capacity for Smarter Scale‑Up
In the rapidly evolving competitive innovation landscape, a biopharmaceutical contract manufacturing organization leveraged our capacity assessment framework to identify supply chain gaps and strategize low-risk scale up.
Ensuring Market Readiness in Advanced Therapy Development
A developer in advanced therapies used regulatory monitoring to stay ahead of changing requirements and improve launch readiness.
Identifying Systemic Discontinuation Risks Across Gene Therapy Development
A gene therapy innovator used discontinuation-risk analysis to evaluate downstream commercial and development risks.
Addressing Unmet Needs in Revenue Management for Healthcare Industry
A healthcare company leveraged unmet-need analysis to sharpen growth strategy and resource allocation.
Benchmarking Medical Exoskeletons to Drive Competitive Clarity
The client used benchmarking analysis to compare product positioning and market readiness across devices.
Identifying High-Impact Partnerships for a Biologics CMO
A biologics CMO used partner analysis to uncover collaboration opportunities with greater strategic value.
Data-Driven Trial Tracking for Smarter GLP-1 Development
A development-stage organization used trial tracking to stay current on GLP-1 pipeline progress and competitor moves.
Competitive AI in Healthcare Ecosystem Mapping
The client used business-model assessment to map ecosystem dynamics and sharpen its competitive positioning.
Strengthening Launch Readiness in the Evolving RTU Syringe Landscape
Launch monitoring helped the client identify fast-moving market signals and improve go-to-market confidence.
Strategic ADC Manufacturing and Capital Allocation Assessment
Deal-tracking intelligence helped the client evaluate strategic moves and optimize capital allocation decisions.
AI-Driven Clinical Trials Customer Feedback Mapping
A pharmaceutical organization leveraged customer sentiment analysis to understand feedback trends and support product and strategy decisions.
Evidence-Based Insights for Product Strategy
A biotech company used product profiling analysis to understand competitive positioning and strengthen its strategic product portfolio decisions.
Evidence-Based Insights for Product Strategy
A biotech company used product profiling analysis to understand competitive positioning and strengthen its strategic product portfolio decisions.
Unlocking Capital Through Investor Intelligence
A development-stage pharma company used investment analysis to identify key investors, understand funding trends, and strengthen its fundraising strategy.
Integrated Pricing Strategy and Payer Sentiment Analysis for a Leading CAR-T Developer
A CAR-T therapy developer leveraged pricing and payer sentiment analysis to optimize pricing strategy and accelerate market access.
De-Risking Acquisitions in Wearable Injectors Market
A leading injectable device developer used our M&A Tracking framework to prioritize acquisition targets and de-risk deal execution.
The Social Verdict: Real-Time Insights for Growth
A biopharma company leveraged social monitoring to capture real-time HCP insights and optimize engagement strategies.
Navigating LNP Innovation: From Raw Patent Data to Risk-Mitigated Market Entry
A Japanese pharma company used patent intelligence to uncover white spaces and guide risk-mitigated market entry.
The Emerging Tech Map: Unlocking Insights Through Scouting Intelligence
A pharma platform developer leveraged technology scouting to pinpoint emerging innovations and sharpen strategic positioning.
